Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 264

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 264
---
 value of stock options outstanding at June 30, 2024, was nil (2023 - nil) and the aggregate intrinsic value of stock options exercisable at June 30, 2024, was nil (2023 - nil). As of June 30, 2024, there was $ 322 in unrecognized compensation expense that will be recognized over the next 2.02 years.

The following table sets forth changes in unvested stock options under all plans:

| Unvested at June 30, 2022 |     | Number ofoptions(in thousands) |  84 |   |     | Weightedaverageexerciseprice$ | 51.23 |
|:--------------------------|:----|:-------------------------------|----:|:--|:----|:------------------------------|------:|
| Granted                   |     |                                |  78 |   |     |                               |  8.79 |
| Vested                    |     |                                | (44 | ) |     |                               | 48.53 |
| Unvested at June 30, 2023 |     |                                | 118 |   |     |                               | 24.12 |
| Granted                   |     |                                |  89 |   |     |                               |  4.66 |
| Vested                    |     |                                | (70 | ) |     |                               | 19.44 |
| Forfeited                 |     |                                | (31 | ) |     |                               |  8.26 |
| Unvested at June 30, 2024 |     |                                | 106 |   |     |                               | 15.57 |

The aggregate intrinsic value of unvested stock options at June 30, 2024 was nil (2023 - nil ). The unvested stock options have a remaining weighted average contractual term of 7.72 (2023 – 8.83 ) years.

Restricted stock units

On August 1, 2022, the Company issued 18 RSUs to its officers. Subject to providing continuous service to the Company, the RSUs vest in four equal annual installments commencing August 1, 2023. The RSUs were valued using the closing price of the Company’s common stock on the date of issuance with the total expense of $ 155 being recognized over the vesting period of four years .

On June 1, 2023, the Company issued 60 RSU to one